QLD Biotherapeutics Inc Revenue
Biotechnology Research • 
Boston, Massachusetts, United States • 21-50 Employees
QLD Biotherapeutics Inc revenue & valuation
| Annual revenue | $2,395,540 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $7,700,000 |
| Total funding | No funding |
Key Contacts at QLD Biotherapeutics Inc
Shawn Xiangbin
Co-Founder And Chief Operating Officer
Shengwen Zhang
Executive Director
Hailong Hou
Associate Director, Project Leader
Li Gan
Associate Director
Travis Grim
Associate Director
Moyar Ge
Director
Zhou Han
Associate Director
Company overview
| Headquarters | 50 Soldiers field Place, Boston, Massachusetts 02135, US |
| Phone number | +16172088221 |
| Websites | |
| NAICS | 541714 |
| Keywords | Incubator, Cell And Gene Therapy, Aav Gene Therapy, Nk Cell Therapy |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
QLD Biotherapeutics Inc Email Formats
QLD Biotherapeutics Inc uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@qldbio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@qldbio.com | 100% |
About QLD Biotherapeutics Inc
QLD biotherapeutic located in Boston, Massachusetts with over 24,000 SF state-of-the-art labs and facilities. We have a R&D team focusing on the research and development of advanced cell and gene therapies using innovative technologies to treat devastating diseases, such as cancer and neurodegenerative diseases. At same time, we provide the platform to connect and support the innovation and entrepreneurship, and we offer entrepreneurs and startup companies with venture capital investment, suitable laboratory/office space /infrastructure, and access to the company’s research expertise. We are looking for the breakthrough biotechnologies/innovative products for in-licensing, investment/incubation, or collaboration. QLD biotherapeutic is funded by Qilu Pharmaceutical, which is a leading pharmaceutical company in China (around top 5 in China) with a focus on the R&D (2 R&D sites in China and 3 R&D sites in US), manufacturing (10 sites), sales and marketing of pharmaceutical and health products. We have over 36,000 employees globally, including 3,000 R&D scientists and over 600 clinical development FTE. We have over 40 scientific leaders with education and work experience in the US at Pfizer, Amgen, Roche, Takeda, Johnson & Johnson, Merck and Genentech, etc., and over 200 pipeline products and projects including more than 80 innovative programs and 30 biologics programs, 9 IND filings in 2021(US, China, Australia). In 2021 pandemic year, we achieved $5.2 billion in the revenue and significant annual investment in R&D. Qilu Pharmaceutic is actively looking for clinical assets/technologies to develop in China’s market, also looking for out-licensing partners for Qilu’s 16 clinical stage pipelines in global markets.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
QLD Biotherapeutics Inc has 8 employees across 4 departments.
Departments
Number of employees
Funding Data
QLD Biotherapeutics Inc has never raised funding before.
Egypt
Norway
United Kingdom
Germany
India
Romania
Nigeria
Frequently asked questions
4.8
40,000 users
